Pfizer (NYSE:PFE) Delves Into Animal Health

Pfizer (NYSE:PFE) Animal Health has decided to integrate Alpharma to provide diversified products and services. Pfizer (NYSE:PFE) Delves Into Animal Health The global pharmaceutical company Pfizer (NYSE:PFE) announced that its Animal Health division is planning to incorporate Alpharma, the wholly owned subsidiary of King Pharmaceuticals, into its business group to provide various products and services. The company acquired King Pharmaceuticals in February. The company can strengthen its market by utilizing Alpharma's water-soluble therapeutics and medicated feed additives. President of Pfizer (NYSE:PFE) Animal Health for U.S. Clint Lewis said, "We want to be viewed by customers and colleagues as the best animal health company with exceptional people, products and services." Pfizer Inc. (NYSE:PFE) stocks were at 19.76 at the end of the last day’s trading. There’s been a 15.2% change in the stock price over the past 3 months. Pfizer Inc. (NYSE:PFE) Analyst Advice Consensus Opinion: Moderate Buy Mean recommendation: 1.52 (1=Strong Buy, 5=Strong Sell) 3 Months Ago: 1.58 Zack’s Rank: 2 out of 15 in the industry
Negocioenlinea
tdp2664
E money daily